Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:China
|
| gptkbp:founded |
1989
|
| gptkbp:headquarters_location |
gptkb:Linhai,_Zhejiang,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Huahai Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Jingsong_Li
|
| gptkbp:market |
global
|
| gptkbp:notableEvent |
NDMA impurity recall in valsartan
|
| gptkbp:products |
active pharmaceutical ingredients
finished dosage forms |
| gptkbp:stockExchange |
gptkb:Shanghai_Stock_Exchange
|
| gptkbp:stockSymbol |
600521
|
| gptkbp:website |
http://www.huahaipharm.com/
|
| gptkbp:bfsParent |
gptkb:Jiangsu_Huahai
|
| gptkbp:bfsLayer |
6
|